Sarepta Therapeutics Inc (0L35)
LSE
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 424.1M | 1.31B | 1.64B | 1.82B | 2.98B | 3.15B | 3.13B | 3.26B |
Total Current Assets | 373.48M | 1.23B | 1.43B | 1.47B | 2.49B | 2.6B | 2.56B | 2.58B |
Cash and Equivalents | 122.42M | 599.69M | 370.83M | 835.08M | 1.5B | 2.12B | 966.78M | 428.43M |
Total Non-Current Assets | 336.69M | 789.22M | 1.03B | 818.19M | 761.76M | 928.01M | 384.95M | 859.34M |
Total Liabilities | 87.41M | 518.75M | 609.8M | 1B | 2.22B | 2.22B | 2.74B | 2.41B |
Total Current Liabilities | 75.42M | 88.33M | 173.69M | 264.77M | 416.03M | 452.73M | 619.6M | 653.66M |
Total Non-Current Liabilities | 18.03M | 855.29M | 856.66M | 1.42B | 2.8B | 2.86B | 3.67B | 2.88B |
Total Equity | 336.69M | 789.22M | 1.03B | 818.19M | 761.76M | 928.01M | 384.95M | 859.34M |
Common Equity | 5k | 6k | 7k | 8k | 8k | 9k | 9k | 9k |
Retained Earnings | -1.17B | -1.22B | -1.58B | -2.29B | -2.85B | -3.21B | -3.91B | -4.45B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.